A drug with the SMILES Nc1c(C(=O)Nc2cccc(C(=O)O)c2)sc2nc3c(cc12)CCCC3 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 12.090%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Nc1c(C(=O)Nc2cccc(C(=O)O)c2)sc2nc3c(cc12)CCCC3
Nc1c(C(=O)Nc2cccc(C(=O)O)c2)sc2nc3c(cc12)CCCC3
3-[(3-amino-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carbonyl)amino]benzoic acid